Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
The C4EB study-Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study.
PLoS One. 2022 Dec 12;17(12):e0277512. doi: 10.1371/journal.pone.0277512. eCollection 2022.
PLoS One. 2022.
PMID: 36508401
Free PMC article.
Patients with the genetic blistering skin condition epidermolysis bullosa (EB) report severe pain as a consequence of skin and mucous membrane lesions including blisters, wounds, and scars. ...The C4EB study is an investigator-initiated, single-centre, randomized, double-b …
Patients with the genetic blistering skin condition epidermolysis bullosa (EB) report severe pain as a consequence of skin and mucous …
Cannabinoids for the Treatment of Dermatologic Conditions.
Sivesind TE, Maghfour J, Rietcheck H, Kamel K, Malik AS, Dellavalle RP.
Sivesind TE, et al.
JID Innov. 2022 Jan 13;2(2):100095. doi: 10.1016/j.xjidi.2022.100095. eCollection 2022 Mar.
JID Innov. 2022.
PMID: 35199092
Free PMC article.
Review.
Selective CB receptor type 2 agonists were found to be effective in treating diffuse cutaneous systemic sclerosis and dermatomyositis. Dronabinol showed efficacy for trichotillomania. Sublingual cannabidiol and delta-9-tetrahydrocannabinol were successful in treating the p …
Selective CB receptor type 2 agonists were found to be effective in treating diffuse cutaneous systemic sclerosis and dermatomyositis. Dr …
Item in Clipboard
Cite
Cite